Ann: Dates for First Half FY24 Results & Investor Webinar, page-34

Notice how the whole premise of the ZOLEO offering is based on being value for money.
Which is driven by the lowest-priced device!
This is clearly stated in the ZOLEO JV's marketing materials, as seen below from LinkedIn this week.
Who is funding the abnormally low margins on the ZOLEO device? Beam Shareholders of course.
Who is benefiting from high recurring revenues from these device subsidies? Roadpost shareholders of course.
Roadpost haven't held up their end of the JV arrangement, as they clearly have no intention to run a profitable JV.
They just want to sit on their pool of growing recurring revenue.
I hope this point is key to the arbitration discussions, but our Board / Management signed the contract, so are they to blame?